Literature DB >> 11552031

Clinical and molecular findings in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.

S Salvi1, F M Santorelli, E Bertini, R Boldrini, C Meli, A Donati, A B Burlina, C Rizzo, M Di Capua, G Fariello, C Dionisi-Vici.   

Abstract

The authors report the clinical and molecular findings in eight patients with hyperornithinemia, hyperammonemia, and homocitrullinuria (HHH) syndrome. The most consistent neurologic finding was spastic paraparesis, seen in five of the eight patients. However, all showed signs of pyramidal tract involvement. A broad spectrum of pathogenetic mutations (including missense, nonsense, splice site, insertion, and deletions) were identified in the ORNT1 gene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11552031     DOI: 10.1212/wnl.57.5.911

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

1.  Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome in adulthood: a rare recognizable condition.

Authors:  Massimiliano Filosto; Antonella Alberici; Alessandra Tessa; Alessandro Padovani; Filippo M Santorelli
Journal:  Neurol Sci       Date:  2012-12-18       Impact factor: 3.307

2.  HHH syndrome (hyperornithinaemia, hyperammonaemia, homocitrullinuria), with fulminant hepatitis-like presentation.

Authors:  S Fecarotta; G Parenti; P Vajro; A Zuppaldi; R Della Casa; M T Carbone; A Correra; G Torre; S Riva; C Dionisi-Vici; F M Santorelli; G Andria
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

3.  Chronic postnatal ornithine administration to rats provokes learning deficit in the open field task.

Authors:  Carolina Maso Viegas; Estela Natacha Brandt Busanello; Anelise Miotti Tonin; Mateus Grings; Alana Pimentel Moura; Luciana Ritter; Angela Zanatta; Lisiane Aurélio Knebel; Vannessa Araujo Lobato; Letícia Ferreira Pettenuzzo; Carmen Regla Vargas; Guilhian Leipnitz; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2012-06-16       Impact factor: 3.584

Review 4.  Hereditary spastic paraparesis in adults associated with inborn errors of metabolism: a diagnostic approach.

Authors:  F Sedel; B Fontaine; J M Saudubray; O Lyon-Caen
Journal:  J Inherit Metab Dis       Date:  2007-10-22       Impact factor: 4.982

Review 5.  Inborn errors of metabolism and motor disturbances in children.

Authors:  A García-Cazorla; N I Wolf; M Serrano; B Pérez-Dueñas; M Pineda; J Campistol; E Fernández-Alvarez; J Colomer; S DiMauro; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2009-10       Impact factor: 4.982

Review 6.  Ammonia toxicity to the brain.

Authors:  Olivier Braissant; Valérie A McLin; Cristina Cudalbu
Journal:  J Inherit Metab Dis       Date:  2012-10-30       Impact factor: 4.982

7.  Impairment of brain redox homeostasis caused by the major metabolites accumulating in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome in vivo.

Authors:  Carolina Maso Viegas; Anelise Miotti Tonin; Angela Zanatta; Bianca Seminotti; Estela Natacha Brandt Busanello; Carolina Gonçalves Fernandes; Alana Pimentel Moura; Guilhian Leipnitz; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2012-07-15       Impact factor: 3.584

Review 8.  Suggested guidelines for the diagnosis and management of urea cycle disorders.

Authors:  Johannes Häberle; Nathalie Boddaert; Alberto Burlina; Anupam Chakrapani; Marjorie Dixon; Martina Huemer; Daniela Karall; Diego Martinelli; Pablo Sanjurjo Crespo; René Santer; Aude Servais; Vassili Valayannopoulos; Martin Lindner; Vicente Rubio; Carlo Dionisi-Vici
Journal:  Orphanet J Rare Dis       Date:  2012-05-29       Impact factor: 4.123

9.  Insights into the mutation-induced HHH syndrome from modeling human mitochondrial ornithine transporter-1.

Authors:  Jing-Fang Wang; Kuo-Chen Chou
Journal:  PLoS One       Date:  2012-01-26       Impact factor: 3.240

Review 10.  Childhood-onset hereditary spastic paraplegia and its treatable mimics.

Authors:  Darius Ebrahimi-Fakhari; Afshin Saffari; Phillip L Pearl
Journal:  Mol Genet Metab       Date:  2021-06-24       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.